
Overview
Benjamin Siegel, MD, is an assistant professor of Neurology at Children’s National Hospital and the George Washington University School of Medicine and Health Sciences. Dr. Siegel grew up in Atlanta. He attended the University of Pittsburgh, where he earned his undergraduate degree in neuroscience and psychology. Dr. Siegel returned to Atlanta to attend medical school at Emory University School of Medicine. He completed his child neurology residency at Emory University and Children’s Healthcare of Atlanta, followed by a pediatric neuro-oncology fellowship at Children’s National in Washington, D.C. Dr. Siegel’s clinical and research focus is on neurofibromatosis and neurologic complications of cancer. At Children’s National, Dr. Siegel is the clinical co-director of the Gilbert Family Neurofibromatosis Institute, which cares for over 400 patients with neurofibromatosis annually. He serves as the site principal investigator for the Neurofibromatosis Clinical Trials Consortium (NFCTC) and the NF1 Glioma Research Center at Children’s National. Dr. Siegel is board-certified in neurology with special qualification in child neurology. He maintains medical licensure in the District of Columbia, Virginia and Maryland, and telehealth registration in West Virginia. He is an active member in the Society for Neuro-Oncology, Child Neurology Society, and American Academy of Neurology and serves as the Neuroscience Responsible Investigator for the Children’s Oncology Group at Children’s National. Outside of work, Dr. Siegel enjoys spending time with his wife and daughter, cycling, cooking and reading. Publications PUBMED.
His clinical expertise encompasses Neurofibromatosis, Pediatric Low-Grade Glioma (pLGG), Gliomatosis Cerebri, Epilepsy in Children, and Thrombectomy.
Dr. Siegel is board certified in American Board Of Psychiatry And Neurology, 2023. He is actively involved in clinical research, co-authoring 19 peer reviewed articles.
Specialties
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
9850 Key West Avenue, Rockville, MD 20850
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Telehealth Video Visit
William D. Gaillard, MD, professor of neurology and neurophysiology, is chief of the Divisions of Child Neurology and of Epilepsy and Neurophysiology. He is director of the Comprehensive Pediatric Epilepsy Program — one of the leading multidisciplinary pediatric epilepsy programs in the country. As associate director of the Children’s National Research Institute’s Center for Neuroscience Research, he is responsible for overseeing and organizing clinical neuroscience research. Dr. Gaillard is professor of pediatrics and neurology at the George Washington University School of Medicine; Professor of Neurology, Georgetown University; and Adjunct Professor of Hearing and Speech Sciences, University of Maryland, College Park. Additionally, Dr. Gaillard holds longstanding collaborations with the Clinical Epilepsy Section (CES), National Institute of Neurological Disorders and Stroke and NIH. His innovative research utilizes advanced structural and functional imaging to examine the effects of epilepsy on brain structure and function. His pioneering work with functional imaging has changed clinical practice for patients with epilepsy, made important technical contributions to structural and functional imaging methods, and provided fundamental scientific insights on the biology of brain plasticity. Ultimately, the goal of his research is to improve the outcomes and lives of children with epilepsy. Dr. Gaillard is a past president of the American Epilepsy Society. He is past treasurer of the American Epilepsy Society, past chair of the International League Against Epilepsy (ILAE) Commission on Diagnostics, past chair of the ILAE Pediatric Epilepsy Surgery Task Force and past member of the Pediatric Commission. He is a past editor of Epilepsy Research and a past editor of Epilepsia. He is the author of more than 240 peer-reviewed scientific papers and more than 50 chapters and holds longstanding federal and foundation grant funding. Dr. Gaillard is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Epilepsy, Seizures, Epilepsy in Children, Liver Embolization, and Deep Brain Stimulation. Dr. Gaillard is board certified in Pediatrics: American Board Of Pediatrics, 2005, American Board Of Psychiatry And Neurology, and American Board Of Psychiatry And Neurology, 1992. Dr. Gaillard is currently accepting new patients.
Montgomery County
Tammy Tsuchida, MD, PhD, is a professor in the departments of Neurology and Pediatrics at the George Washington University School of Medicine and Health Sciences. She completed her fellowships in child neurology and neurophysiology at the University of California, San Francisco, after finishing medical school at Columbia University Vagelos College of Physicians and Surgeons in 1997. At Children's National Hospital, she is a co-director of the Hemimegalencephaly (HME) Program. She consults and teaches in the Neonatal Neurocritical Care Program and Comprehensive Pediatric Epilepsy Program. Her areas of interest are the study and clinical care of neonates and infants with brain injury, seizures and epilepsy as well as neonatal electroencephalogram (EEG). Dr. Tsuchida has made significant contributions to national EEG guidelines and international recommendations for managing neonatal seizures and epilepsy. Dr. Tsuchida is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Epilepsy in Children, Hemimegalencephaly, Seizures, Epilepsy, and Liver Embolization. Dr. Tsuchida is board certified in Clinical Neurophysiology: American Board Of Psychiatry And Neurology, 2009, Epilepsy: American Board Of Psychiatry And Neurology, 2018, and American Board Of Psychiatry And Neurology, 2003. Dr. Tsuchida is currently accepting new patients.
Johns Hopkins Outpatient Center
Catherine Chu is the director of the Division of Pediatric Neurology and the John M. Freeman Pediatric Epilepsy Center in the Johns Hopkins Department of Neurology, as well as the vice president of child neurology at the Kennedy Krieger Institute. As a child neurologist, epileptologist and clinical neurophysiologist, Dr. Chu cares for children diagnosed with epilepsy and disorders of the nervous system (neurophysiology). She specializes in electroencephalogram (also known as EEG) analysis, seizure localization, surgical planning and neuromodulation for adult and pediatric patients with difficult to control epilepsy. She is nationally and internationally recognized for her work identifying causes of and treatment options for cognitive dysfunction and seizures in epilepsy and neurodevelopmental disorders. Dr. Chu’s team specializes in identifying and developing tools to detect and understand brain rhythms that support complex cognitive functions throughout development, including how these rhythms are disrupted by seizures and neurodevelopmental disorders. Dr. Chu earned her medical degree and a master’s degree in social anthropology from Harvard University. She completed an internship in pediatrics at Massachusetts General Hospital, and then a residency in neurology and child neurology at Massachusetts General and Brigham and Women’s Hospital. After completing two fellowships at Massachusetts General, one in epilepsy and another in clinical neurophysiology, Dr. Chu earned a master’s degree in medical science, focused on clinical investigation, from Harvard Medical School. Dr. Chu is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Benign Rolandic Epilepsy, Epilepsy in Children, Seizures, Epilepsy, and Deep Brain Stimulation. Dr. Chu is board certified in American Board Of Psychiatry And Neurology. Dr. Chu is currently accepting new patients.
Frequently Asked Questions about Dr. Benjamin I. Siegel
How do I make an appointment with Dr. Benjamin I. Siegel?
You can book an appointment with Dr. Benjamin I. Siegel by calling their office at 301-765-5400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Benjamin I. Siegel a top-rated expert for Neurofibromatosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Benjamin I. Siegel is classified as an Experienced expert for Neurofibromatosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Benjamin I. Siegel specialize in?
While Dr. Benjamin I. Siegel is a Pediatrics, they have specific expertise in Neurofibromatosis, Thrombectomy, and Pediatric Low-Grade Glioma (pLGG). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.
Does Dr. Benjamin I. Siegel participate in research or clinical trials?
Yes. Dr. Benjamin I. Siegel has published 19 articles and abstracts on conditions like Neurofibromatosis. You can view a list of Dr. Benjamin I. Siegel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Benjamin I. Siegel accept my insurance?
Dr. Benjamin I. Siegel accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 301-765-5400 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Becker Muscular DystrophyDr. Siegel isExperienced. Learn about Becker Muscular Dystrophy.
- Embryonal Tumor with Multilayered Rosettes
- Epilepsy in ChildrenDr. Siegel isExperienced. Learn about Epilepsy in Children.
- Gliomatosis CerebriDr. Siegel isExperienced. Learn about Gliomatosis Cerebri.
- NeurofibromatosisDr. Siegel isExperienced. Learn about Neurofibromatosis.
- Pediatric Low-Grade Glioma (pLGG)Dr. Siegel isExperienced. Learn about Pediatric Low-Grade Glioma (pLGG).
- ThrombectomyDr. Siegel isExperienced. Learn about Thrombectomy.


